(Total Views: 669)
Posted On: 01/19/2021 11:03:22 AM
Post# of 154137
Dr ZAIUS wrote:
I would like to discuss this statement from the article I just linked:
"As of November 20, 2020, an EUA request for leronlimab for the treatment of COVID-19 had been submitted to the FDA."
My response:
"an EUA request...." (not an application for an EUA)
Nader confirmed what they did. They "requested the FDA adivise Cytodyn as to whether or not they should "apply" for the m/m EUA. Nader said the FDA responded that Cytodyn should wait until we had s/c data.
Yes, rather ambiguous. EUA for m/m was never "applied for".
I would like to discuss this statement from the article I just linked:
"As of November 20, 2020, an EUA request for leronlimab for the treatment of COVID-19 had been submitted to the FDA."
My response:
"an EUA request...." (not an application for an EUA)
Nader confirmed what they did. They "requested the FDA adivise Cytodyn as to whether or not they should "apply" for the m/m EUA. Nader said the FDA responded that Cytodyn should wait until we had s/c data.
Yes, rather ambiguous. EUA for m/m was never "applied for".
(4)
(0)
